Your session is about to expire
← Back to Search
MANUP for Type 2 Diabetes (MANUP-NC Trial)
N/A
Waitlist Available
Research Sponsored by North Carolina Central University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
1) reside in Halifax, County or Alamance County NC; 2) age 21 or older; (3) English language proficient; 4) able to walk unaided; 4) self-reported type 2 diabetes diagnosis.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
MANUP-NC Trial Summary
This trial will examine if a culturally-tailored diabetes education program helps lower A1c in Black men, with the goal of improving diabetes outcomes in this population.
Eligible Conditions
- Type 2 Diabetes
- Self-Efficacy
- Male Gender Identity
- Coping Behavior
MANUP-NC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMANUP-NC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A1c
MANUP-NC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active intervention group (AI)Experimental Treatment1 Intervention
The active intervention group (AI) receiving the active treatment (MANUP intervention) which include diabetes education, diabetes support with a focus on coping techniques (based on John Henryism concepts), physical activity engagement and motivational text messages.
Group II: Delayed intervention group (DI)Active Control1 Intervention
DI participants will only receive motivational text-messages. They will then "flip" and receive full intervention after the AI group has completed the program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MANUP
2022
N/A
~50
Find a Location
Who is running the clinical trial?
University of North Carolina, Chapel HillOTHER
1,499 Previous Clinical Trials
4,176,283 Total Patients Enrolled
North Carolina Central UniversityLead Sponsor
3 Previous Clinical Trials
14,628 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Active intervention group (AI)
- Group 2: Delayed intervention group (DI)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals currently being accepted for this clinical trial?
"This trial is currently looking for suitable candidates. Clinicaltrials.gov first posted this research study on February 12th 2022 and the information was most recently modified on March 9th 2022."
Answered by AI
How many participants have been enrolled in this clinical experiment?
"Affirmative. The clinical trial is currently accruing participants, as indicated on the official clinicaltrials.gov page which was first posted on February 12th 2022 and most recently updated on March 9th 2022. 50 individuals are required to partake in this study at a single medical facility."
Answered by AI
Share this study with friends
Copy Link
Messenger